New Rare Diseases Working Group
CIC has launched a new Rare Diseases Working Group, which aims to: Raise awareness in the use of pharmaceutical cannabinoids in rare diseases (engagement with rare disease charities etc…) Help create robust innovative clinical trials for pharmaceutical cannabinoids through life sciences Look to how we can incentivise industry to invest in rare disease research and […]
Read More